LexaGene (OTCQB:LXXGF - TSX.V:LXG) is a molecular diagnostics company developing an open-access, fully automated system for rapid and sensitive pathogen detection. MiQLab is PCR-based and can detect up to 27 targets at once for testing in human clinical and veterinary diagnostics, as well as food safety testing, and open-access custom testing markets that need critical answers in less time.